Role of rectosigmoidectomy and stripping of pelvic peritoneum in outcomes of patients with advanced ovarian cancer

被引:59
作者
Aletti, Giovanni D. [1 ]
Podratz, Karl C. [1 ]
Jones, Monica B. [1 ]
Cliby, William A. [1 ]
机构
[1] Mayo Clin & Mayo Fdn, Dept Obstet & Gynecol, Rochester, MN 55905 USA
关键词
D O I
10.1016/j.jamcollsurg.2006.06.027
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: The peritoneum of the cul-de-sac is frequently affected in advanced ovarian cancer patients. Stripping of the pelvic peritoneum (SoP) combined with rectosigntoidectomy (RS) in patients with confluent tumor are safe techniques that can eradicate macroscopic disease. We evaluated the therapeutic value of this maximal surgical effort in advanced ovarian cancer. STUDY DESIGN: Data from all consecutive patients with stages IIIC and IV epithelial ovarian cancer, primarily operated on from 1994 through 1998, were collected and analyzed using the chi-square test, Cox regression analysis, and Kaplan-Meier curves including log-rank test. RESULTS: Two hundred forty-four eligible patients were identified; 209 patients had tumor involving the peritoneum of the cul-de-sac. For this subgroup, those who were managed with stripping of the peritoneum (SoP, n = 77) or rectosignioidectomy (RS, N = 57) had improved 5-year overall survivals relative to those who were not (n = 75). (SoP = 37% versus RS = 39% versus neither = 6%; p < 0.0001). In the subgroup of patients with cul-de-sac involvement optimally cytoreduced, we noted a survival benefit for those who were managed with a maximal pelvic surgical effort (5-year overall survival, 38% [SoP] versus 38% [RS] versus 15% [neither]; p = 0.02). When evaluating patients with no macroscopic residual disease, a survival advantage for patients managed with RS compared with Sol? was observed (5-year overall survival, 89% (RS) versus 50% (RS); p = 0.04). CONCLUSIONS: Surgical resection of cul-de-sac disease by Sol? and RS is associated with improved survival in ovarian cancer patients. Tumor resection with en bloc RS may be preferable to allowing microscopic or infiltrative residual tumor.
引用
收藏
页码:521 / 526
页数:6
相关论文
共 11 条
[1]  
BEREK JS, 1984, OBSTET GYNECOL, V64, P715
[2]   Radical oophorectomy with primary stapled colorectal anastomosis for resection of locally advanced epithelial ovarian cancer [J].
Bristow, RE ;
del Carmen, MG ;
Kaufman, HS ;
Montz, FJ .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2003, 197 (04) :565-574
[3]   Procedures required to accomplish complete cytoreduction of ovarian cancer: Is there a correlation with "biological aggressiveness" and survival? [J].
Eisenkop, SM ;
Spirtos, NM .
GYNECOLOGIC ONCOLOGY, 2001, 82 (03) :435-441
[4]  
Hudson C N, 1968, J Obstet Gynaecol Br Commonw, V75, P1155
[5]  
HUDSON C N, 1973, Gynecologic Oncology, V1, P370, DOI 10.1016/0090-8258(73)90029-2
[6]  
*INT FED GYN OBST, 1986, GYNECOL ONCOL, V25, P383
[7]   The effect of bowel resection on survival in advanced epithelial ovarian cancer [J].
Jaeger, W ;
Ackermann, S ;
Kessler, H ;
Katalinic, A ;
Lang, N .
GYNECOLOGIC ONCOLOGY, 2001, 83 (02) :286-291
[8]   Cancer statistics, 2005 [J].
Jemal, A ;
Murray, T ;
Ward, E ;
Samuels, A ;
Tiwari, RC ;
Ghafoor, A ;
Feuer, EJ ;
Thun, MJ .
CA-A CANCER JOURNAL FOR CLINICIANS, 2005, 55 (01) :10-30
[9]   Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer [J].
Mourton, SM ;
Temple, LK ;
Abu-Rustum, NR ;
Gemignani, ML ;
Sonoda, Y ;
Bochner, BH ;
Barakat, RR ;
Chi, DS .
GYNECOLOGIC ONCOLOGY, 2005, 99 (03) :608-614
[10]   Safety and efficacy of low anterior en bloc resection as part of cytoreductive surgery for patients with ovarian cancer [J].
Obermair, A ;
Hagenauer, S ;
Tamandl, D ;
Clayton, RD ;
Nicklin, JL ;
Perrin, LC ;
Ward, BG ;
Crandon, AJ .
GYNECOLOGIC ONCOLOGY, 2001, 83 (01) :115-120